During the past decade, Brain Research Center conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 11 clinical trials were completed, i.e. on average, 31.4% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 9 clinical trials were completed. i.e. 36% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Brain Research Center" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Washington University School of Medicine" with 3 trials sponsored, "Alzheon Inc." with 2 trials sponsored, "Anavex Life Sciences Corp." with 2 trials sponsored and "Biogen" with 2 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Brain Research Center" #1 collaborator was "National Institute on Aging (NIA)" with 5 trials as a collaborator, "Alzheimer's Association" with 3 trials as a collaborator, "Amsterdam UMC, location VUmc" with 3 trials as a collaborator, "Accelerating Medicines Partnership (AMP)" with 2 trials as a collaborator and "Anavex Australia Pty Ltd." with 2 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Brain Research Center" are "Alzheimer Disease" (15 trials), "Alzheimer's Disease" (8 trials), "Dementia" (6 trials), "Alzheimers Disease" (3 trials) and "Alzheimers Disease, Familial" (3 trials). Many other conditions were trialed in "Brain Research Center" in a lesser frequency.

Most popular intervention types in "Brain Research Center" are "Drug" (36 trials), "Other" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Gantenerumab" (7 trials), "Lecanemab" (3 trials), "BI 409306" (2 trials) and "Donanemab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Brain Research Center" are 37 trials for "All" genders.

Currently, there are NaN active trials in "Brain Research Center". undefined are not yet recruiting, 10 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Brain Research Center, 1 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Brain Research Center, 2 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".